http://www.biopharminternational.com/biopharm/Outsourcing/Article/list/43001 Trends and best practices in outsourcing, including technology transfer, contract negotiation, project management, auditing providers, and the emergence of China and India. 2013-06-19T10:24:20Z http://www.biopharminternational.com/biopharm/Outsourcing/Drug-Approval-Trends-Dont-Extend-to-CMOs/ArticleStandard/Article/detail/815156?contextCategoryId=43001&ref=25 Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting. 2013-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/242013/815156null XML http://www.biopharminternational.com/biopharm/Outsourcing/Outsourcings-Modest-Role-as-a-Cost-Containment-Str/ArticleStandard/Article/detail/813384?contextCategoryId=43001&ref=25 Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon. 2013-05-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/202013/813384null XML http://www.biopharminternational.com/biopharm/Regulation+and+Compliance/Navigating-Emerging-Markets-mdash-Latin-America/ArticleStandard/Article/detail/810540?contextCategoryId=43001&ref=25 Latin America's diverse growing market seeks regulatory harmonization. 2013-04-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/152013/810540null XML http://www.biopharminternational.com/biopharm/Outsourcing/Strategic-Partnering-for-Manufacturing/ArticleStandard/Article/detail/810541?contextCategoryId=43001&ref=25 An innovative approach to capacity management. 2013-04-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/152013/810541null XML http://www.biopharminternational.com/biopharm/Feature+Rotating+Article/Securing-the-Supply-Chain/ArticleStandard/Article/detail/809082?contextCategoryId=43001&ref=25 A Q&A with SAFC and BioReliance about sourcing and risk mitigation for raw materials. 2013-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142013/809082/SAFC_155127069_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Quality-and-Regulatory-Leadership-Right-Sizing-Nee/ArticleStandard/Article/detail/809084?contextCategoryId=43001&ref=25 This article examines the options to best match needs and spending for quality and regulatory leadership. 2013-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142013/809084null XML http://www.biopharminternational.com/biopharm/Feature+Rotating+Article/CROs-in-a-Global-State-of-Mind/ArticleStandard/Article/detail/809083?contextCategoryId=43001&ref=25 CROs are keeping pace with the increased globalization of the biopharmaceutical/pharmaceutical industry. 2013-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142013/809083/CROsGlobal_83112715_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Feature+Rotating+Article/Achieving-More-Effective-and-Efficient-GMP-Auditin/ArticleStandard/Article/detail/809085?contextCategoryId=43001&ref=25 The authors present solutions based on a review of current service offerings and their audit experience. 2013-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142013/809085/Kettelhot_139467698_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Managing-Contract-Manufacturing-Organization-Relat/ArticleStandard/Article/detail/809086?contextCategoryId=43001&ref=25 Successful management of the CMO/client relationship should include open communication and trust. 2013-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142013/809086/136594619_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Emerging-Outsourcing-Trends-in-2013/ArticleStandard/Article/detail/809081?contextCategoryId=43001&ref=25 BioPlan's outsourcing survey gives insight on top activities, budgets, and growth trends in biopharmaceutical outsourcing. 2013-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142013/809081/BP0313supp_thum_Img_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Outsourcing-Nontraditional-Protein-Expression-Syst/ArticleStandard/Article/detail/809069?contextCategoryId=43001&ref=25 Growth is seen in outsourcing of insect- and plant-cell-based bioproduction expression systems. 2013-03-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142013/809069null XML http://www.biopharminternational.com/biopharm/Outsourcing/End-of-the-Dedicated-CMO/ArticleStandard/Article/detail/804366?contextCategoryId=43001&ref=25 Is the contract-only CMO an endangered species? 2013-02-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/052013/804366null XML http://www.biopharminternational.com/biopharm/Outsourcing/Offshoring-Biomanufacturing/ArticleStandard/Article/detail/802141?contextCategoryId=43001&ref=25 Will international biomanufacturing outsourcing become mainstream in this decade? 2013-01-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/022013/802141null XML http://www.biopharminternational.com/biopharm/Good+Manufacturing+Practices/Navigating-Emerging-Markets/ArticleStandard/Article/detail/798945?contextCategoryId=43001&ref=25 An introduction to a new series on manufacturing within global markets. 2012-12-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/492012/798945/200471241-001_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Basic+Training/Stability-in-Biopharmaceutical-Storage/ArticleStandard/Article/detail/796149?contextCategoryId=43001&ref=25 Patrick Jackson of Vindon Scientific offers key considerations for choosing an outsourced sample storage facility. 2012-11-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/452012/796149null XML http://www.biopharminternational.com/biopharm/Quality/EU-Sets-Guidelines-for-Biosimilar-mAbs/ArticleStandard/Article/detail/796152?contextCategoryId=43001&ref=25 The European Medicines Agency has added granularity to its biosimilars approval pathway by releasing a guideline on mAbs. 2012-11-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/452012/796152/dv321052_3_cmyk_Web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Creating-a-Holistic-Procurement-System/ArticleStandard/Article/detail/796146?contextCategoryId=43001&ref=25 The procurement organization rethinks sourcing for maximum efficiency and results. 2012-11-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/452012/796146null XML http://www.biopharminternational.com/biopharm/Outsourcing/Sizing-the-Market-for-Contract-Manufacturing/ArticleStandard/Article/detail/791283?contextCategoryId=43001&ref=25 Measuring the size of the market for contract manufacturing services requires a careful hand. 2012-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/402012/791283null XML http://www.biopharminternational.com/biopharm/Vaccine+Manufacturing+Articles/Considerations-in-Outsourced-Vaccine-Manufacturing/ArticleStandard/Article/detail/791277?contextCategoryId=43001&ref=25 Marco Chacon of Paragon Bioservices discusses the challenges associated with outsourced vaccine manufacturing. 2012-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/402012/791277/BP1012_Cover_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/A-Manufacturing-Capacity-Sharing-Model/ArticleStandard/Article/detail/791289?contextCategoryId=43001&ref=25 The manufacturing capacity-sharing model between Merck and MedImmune ushers in a new paradigm of "co-opetition." 2012-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/402012/791289null XML http://www.biopharminternational.com/biopharm/Perspectives+on+Outsourcing/The-Macro-View/ArticleStandard/Article/detail/787740?contextCategoryId=43001&ref=25 The weak global economy adds to the challenges of bio/pharma companies and their suppliers. 2012-09-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/362012/787740null XML http://www.biopharminternational.com/biopharm/Outsourcing/Gauging-Biopharm-Outsourcing/ArticleStandard/Article/detail/784476?contextCategoryId=43001&ref=25 Budgets for biopharma activities are gaining in select functional areas, except outsourcing. 2012-08-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/322012/784476null XML http://www.biopharminternational.com/biopharm/Downstream+Processing/Biomanufacturing-Innovation/ArticleStandard/Article/detail/781182?contextCategoryId=43001&ref=25 Industry wants more innovation, but can suppliers meet customers' needs? 2012-07-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/282012/781182null XML http://www.biopharminternational.com/biopharm/Quality/Determining-Process-Quality-Metrics-for-CMOs/ArticleStandard/Article/detail/775168?contextCategoryId=43001&ref=25 Implementing quality by design makes the determination of quality metrics across CMOs and sponsors essential. 2012-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/212012/775168/BP0612_14_sb10065861u-001_flash.jpg XML http://www.biopharminternational.com/biopharm/Quality/25-Years-of-Biopharmaceutical-Innovation-An-Expert/ArticleStandard/Article/detail/775157?contextCategoryId=43001&ref=25 Industry experts discuss significant achievements. Plus: What's in store for the future. 2012-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/212012/775157/BP0612_54_Covers-1988_Jan_flash.jpg XML http://www.biopharminternational.com/biopharm/Quality/Developing-Discoveries-into-New-Therapeutics/ArticleStandard/Article/detail/775169?contextCategoryId=43001&ref=25 Formulators and developers are at the heart of the industry's basic premise—they are saving lives. 2012-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/212012/775169null XML http://www.biopharminternational.com/biopharm/Quality/Know-the-Regulations/ArticleStandard/Article/detail/775164?contextCategoryId=43001&ref=25 The contract provider needs to know as much as the NDA holder. 2012-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/212012/775164null XML http://www.biopharminternational.com/biopharm/Outsourcing/Channeling-Steve-Jobs/ArticleStandard/Article/detail/771929?contextCategoryId=43001&ref=25 Service providers must focus on delivering a superior customer experience. 2012-05-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/182012/771929null XML http://www.biopharminternational.com/biopharm/From+the+Editor/Some-Supply-Chain-Lessons-Can-Go-a-Long-Way/ArticleStandard/Article/detail/771922?contextCategoryId=43001&ref=25 No matter the time or cost, knowing what's going on inside your facilities is always going to be worth the effort. 2012-05-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/182012/771922null XML http://www.biopharminternational.com/biopharm/Quality/A-New-Way-to-Think-About-Outsourcing-Partnerships/ArticleStandard/Article/detail/771930?contextCategoryId=43001&ref=25 Future sponsor-contract provider relationships will require more integration. 2012-05-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/182012/771930null XML http://www.biopharminternational.com/biopharm/Quality/A-Look-at-INTERPHEX-2012/ArticleStandard/Article/detail/767888?contextCategoryId=43001&ref=25 Collaboration can begin with a conversation. 2012-04-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142012/767888null XML http://www.biopharminternational.com/biopharm/Quality/Small-Changes-System-Wide-Impact/ArticleStandard/Article/detail/767893?contextCategoryId=43001&ref=25 A closer look at elastomer changeout times provides one example of using industry knowledge to improve operations and cost. 2012-04-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142012/767893null XML http://www.biopharminternational.com/biopharm/Outsourcing/Ways-to-Recover-Lost-Margins/ArticleStandard/Article/detail/767899?contextCategoryId=43001&ref=25 Recovery audits and other best practices in procurement can improve the bottom line. 2012-04-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142012/767899null XML http://www.biopharminternational.com/biopharm/Quality/Considerations-in-Biopharmaceutical-Outsourcing/ArticleStandard/Article/detail/763584?contextCategoryId=43001&ref=25 Because of the complexity of the manufacturing processes for biologics, transfer of these processes to a contract manufacturer presents challenges. 2012-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102012/763584null XML http://www.biopharminternational.com/biopharm/Outsourcing/Biotherapeutics-Outpace-Conventional-Therapies/ArticleStandard/Article/detail/763582?contextCategoryId=43001&ref=25 Growth in infrastructure and process-development capabilities will be required to support the biologics market. 2012-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102012/763582/BPsupp0312_20_117861306_flash.jpg XML http://www.biopharminternational.com/biopharm/Quality/Managing-the-Quality-Relationship-for-a-Contractua/ArticleStandard/Article/detail/763583?contextCategoryId=43001&ref=25 The author describes an equation that can be used to define the Quality relationship between a contract manufacturing organization and a client, including how to factor in both party's needs and regulatory commitments. 2012-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102012/763583null XML http://www.biopharminternational.com/biopharm/Outsourcing/Empire-State-Drug-Development/ArticleStandard/Article/detail/763580?contextCategoryId=43001&ref=25 An architectural wonder teaches the biopharmaceutical industry a valuable lesson in project management. 2012-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102012/763580/BPsupp0312_24_Vetter-Diagram_Opening-Art_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Biopharmaceutical-Outsourcing-Trends-The-Next-Deca/ArticleStandard/Article/detail/763578?contextCategoryId=43001&ref=25 New outsourcing industry sectors have become multibillion-dollar industries. 2012-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102012/763578/BPsupp0312_04_200471241_001_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Meeting-Challenges-in-Contract-RampD/ArticleStandard/Article/detail/763577?contextCategoryId=43001&ref=25 Representatives from leading CROs weigh in on key challenges tied to the biopharmaceutical R&D, including issues regarding bioequivalence, platform technologies, process analytics, and more. 2012-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102012/763577null XML http://www.biopharminternational.com/biopharm/Quality/Smart-Outsourcing-Strategic-Alignment-Risk-Managem/ArticleStandard/Article/detail/763579?contextCategoryId=43001&ref=25 Outsourcing in the pharmaceutical industry, until recently, has been largely confined to commercial manufacturing, packaging, and support for clinical trials. 2012-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102012/763579null XML http://www.biopharminternational.com/biopharm/Outsourcing/CMOs-Face-a-Kodak-Moment/ArticleStandard/Article/detail/763566?contextCategoryId=43001&ref=25 The evolving bio/pharmaceutical business model poses risk for CMOs. 2012-03-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102012/763566null XML http://www.biopharminternational.com/biopharm/Outsourcing/Preparing-For-the-New-China/ArticleStandard/Article/detail/757939?contextCategoryId=43001&ref=25 China's healthcare reforms generate uncertainty for its domestic pharmaceutical market. 2012-02-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/062012/757939/BP0212_26_93522323_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/What-the-2011-Census-of-India-Reveals-for-Pharma/ArticleStandard/Article/detail/757929?contextCategoryId=43001&ref=25 The census reveals the state of the population of India's health and the potential for growth in the healthcare market. 2012-02-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/062012/757929/BP0212_28_sb10065413a-001_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/The-Challenges-of-Emerging-Markets/ArticleStandard/Article/detail/757932?contextCategoryId=43001&ref=25 The difficulties of doing business in China are offset by its adoption of more stringent GMP standards. 2012-02-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/062012/757932null XML http://www.biopharminternational.com/biopharm/Outsourcing/Trends-and-Challenges-in-Biologics-Outsourcing-A-Q/ArticleStandard/Article/detail/757940?contextCategoryId=43001&ref=25 Stephen Taylor PhD, vice-president and commercial director at Fujifilm Diosynth Biotechnologies, addresses some of the challenges facing biologics outsourcing. 2012-02-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/062012/757940null XML http://www.biopharminternational.com/biopharm/Outsourcing/Biomanufacturing-Outsourcing-Outlook/ArticleStandard/Article/detail/757935?contextCategoryId=43001&ref=25 Industry optimism is on the rise for 2012. 2012-02-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/062012/757935null XML http://www.biopharminternational.com/biopharm/Quality/Sustainable-Investment/ArticleStandard/Article/detail/757937?contextCategoryId=43001&ref=25 Industry announces plans for year ahead at annual JPMorgan Global Healthcare Conference. 2012-02-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/062012/757937null XML http://www.biopharminternational.com/biopharm/Perspectives+on+Outsourcing/Contract-Services-in-2012/ArticleStandard/Article/detail/754436?contextCategoryId=43001&ref=25 Some recent private-equity buyouts of CROs show both the upside and downside for investors. 2012-01-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/532011/754436null XML http://www.biopharminternational.com/biopharm/Final+Word/USAID-Moves-Global-Healthcare-Initiatives-Forward/ArticleStandard/Article/detail/754434?contextCategoryId=43001&ref=25 Government plans require investment, partnership, and industry collaboration. 2012-01-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/532011/754434null XML http://www.biopharminternational.com/biopharm/Quality%2FGMP%2FValidation++Whitepapers/Global-Economic-Woes-Overshadow-Biotech-Industry-A/ArticleStandard/Article/detail/754427?contextCategoryId=43001&ref=25 Greater emphasis on focus and efficiency for companies as market demands value in 2012. 2012-01-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/532011/754427null XML http://www.biopharminternational.com/biopharm/Outsourcing/Troublesome-Signs-for-BioPharmaceutical-RampD/ArticleStandard/Article/detail/750856?contextCategoryId=43001&ref=25 A dearth of late-stage candidates could hurt the pharmaceutical services market in the future. 2011-12-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/492011/750856null XML http://www.biopharminternational.com/biopharm/Quality%2FGMP%2FValidation++Whitepapers/The-Employment-Outlook-Brightens/ArticleStandard/Article/detail/750859?contextCategoryId=43001&ref=25 Readers react to the economic turmoil of the past year and look longingly forward to 2012. 2011-12-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/492011/750859/BP1211_22_103772148_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/The-Economic-Challenge-of-PrescriptionndashDiagnos/ArticleStandard/Article/detail/746283?contextCategoryId=43001&ref=25 With the rise in therapeutics comes more complex partnerships. 2011-11-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/442011/746283null XML http://www.biopharminternational.com/biopharm/Outsourcing/Development-and-Commercialization-of-Biosimilars-i/ArticleStandard/Article/detail/746277?contextCategoryId=43001&ref=25 The author explains the current status of India, the challenges, and recommendations that may alleviate these challenges. 2011-11-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/442011/746277/BP1111_Getty_102541740_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Quality/CMOs-Ratchet-up-use-of-Single-Use-Devices-to-Impro/ArticleStandard/Article/detail/746278?contextCategoryId=43001&ref=25 Single-use systems continue to gain traction among biomanufacturers, especially CMOs. 2011-11-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/442011/746278/BP1111_Cvr_T_Web2_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Protein-Engineering/ArticleStandard/Article/detail/746285?contextCategoryId=43001&ref=25 Industrializing design, development, and manufacturing of therapeutic proteins. 2011-11-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/442011/746285null XML http://www.biopharminternational.com/biopharm/Outsourcing/Biosimilars-Technology-Needs/ArticleStandard/Article/detail/746280?contextCategoryId=43001&ref=25 Biosimilar manufacturers need better expression systems and analytical tools to compete. 2011-11-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/442011/746280null XML http://www.biopharminternational.com/biopharm/Outsourcing/Trends-in-Biologics-Outsourcing/ArticleStandard/Article/detail/742605?contextCategoryId=43001&ref=25 A Q&A with Rick Hancock, president of Althea Technologies. This article contains bonus online material. 2011-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/412011/742605null XML http://www.biopharminternational.com/biopharm/Outsourcing/Survey-Examines-Trends-in-the-Outsourcing-Relation/ArticleStandard/Article/detail/742607?contextCategoryId=43001&ref=25 The BioPlan Associates 8th annual survey identifies key outsourcing concerns of sponsor companies. 2011-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/412011/742607/BP1011_IMG_0845-fin_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/How-to-Choose-the-Right-CMO/ArticleStandard/Article/detail/742610?contextCategoryId=43001&ref=25 Knowing in advance what you need can make a huge difference in a sponsor company's success. 2011-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/412011/742610null XML http://www.biopharminternational.com/biopharm/Outsourcing/Preparing-for-the-Last-War/ArticleStandard/Article/detail/742601?contextCategoryId=43001&ref=25 CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models. 2011-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/412011/742601null XML http://www.biopharminternational.com/biopharm/Quality/Contract-Services-Spending-Whos-Spending-What-and-/ArticleStandard/Article/detail/742603?contextCategoryId=43001&ref=25 A survey provides insight into drug companies' plans for spending on outsourced services. This article contains bonus online material. 2011-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/412011/742603null XML http://www.biopharminternational.com/biopharm/Quality/Single-use-Technology-Balancing-the-Risks-and-Rewa/ArticleStandard/Article/detail/737342?contextCategoryId=43001&ref=25 Developing a quality agreement template for single-use systems. 2011-09-02T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/352011/737342null XML http://www.biopharminternational.com/biopharm/Quality/Perception-and-Costs-of-Biotech-Innovation/ArticleStandard/Article/detail/737341?contextCategoryId=43001&ref=25 The lower price of biosimilars will increase patient access to medicines and spur innovation. 2011-09-02T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/352011/737341/BPsupp0911_001_Cover_thumbnail_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Quality/Trends-in-Prefills/ArticleStandard/Article/detail/737343?contextCategoryId=43001&ref=25 An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter. 2011-09-02T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/352011/737343null XML http://www.biopharminternational.com/biopharm/Outsourcing/The-EU-Debt-Crisis-and-CMOs/ArticleStandard/Article/detail/737337?contextCategoryId=43001&ref=25 The EU debt crisis portends of possible negative repercussions for the dose CMO industry. 2011-09-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/352011/737337null XML http://www.biopharminternational.com/biopharm/Quality/Top-1000-Global-Biomanufacturing-Facilities/ArticleStandard/Article/detail/733328?contextCategoryId=43001&ref=25 Insights from real-time ranking of global biomanufacturing capabilities. 2011-08-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/312011/733328/Top1000webNew_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Offshoring-Biomanufacturing/ArticleStandard/Article/detail/733331?contextCategoryId=43001&ref=25 China rises to the top as a destination for international outsourcing. 2011-08-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/312011/733331null XML http://www.biopharminternational.com/biopharm/Perspectives+on+Outsourcing/Offsetting-Budget-Cuts/ArticleStandard/Article/detail/728231?contextCategoryId=43001&ref=25 Better strategies and practices in sourcing and procurement can contribute to the bottom line. 2011-07-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/262011/728231null XML http://www.biopharminternational.com/biopharm/Compliance+Notes/Impact-of-cGMP-on-Supply-Chain/ArticleStandard/Article/detail/728232?contextCategoryId=43001&ref=25 Incorporating regulatory requirements into the product life cycle is crucial. 2011-07-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/262011/728232null XML http://www.biopharminternational.com/biopharm/Quality/Best-Practices-for-Technology-Transfer/ArticleStandard/Article/detail/724376?contextCategoryId=43001&ref=25 Clear documentation and open communication are essential for effective technology transfer. 2011-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/222011/724376/BP0611_Tangir-Opening-Art_Web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Better-Upstream-Technologies/ArticleStandard/Article/detail/724370?contextCategoryId=43001&ref=25 A recent industry survey shows keen interest in improving bioreactors and cell-culture media. 2011-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/222011/724370null XML http://www.biopharminternational.com/biopharm/Outsourcing/Top-1000-Biomanufacturing-Facilities/ArticleStandard/Article/detail/724377?contextCategoryId=43001&ref=25 Knowing where key biomanufacturing facilities are located around the world is essential for decision-making. 2011-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/222011/724377/BP0611_Cover_Image_Web_flash.jpg XML http://www.biopharminternational.com/biopharm/Quality/Outsourcing-Lean-Quality-Manufacturing/ArticleStandard/Article/detail/718075?contextCategoryId=43001&ref=25 Rapid microbial screening provided by contract laboratories can save companies time and money. 2011-05-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/182011/718075/bp0511_Celsis.web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/Supply-Chain-Pain/ArticleStandard/Article/detail/718077?contextCategoryId=43001&ref=25 Addressing supply-chain challenges. 2011-05-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/182011/718077null XML http://www.biopharminternational.com/biopharm/Outsourcing/A-Hard-Look-at-Third-Party-External-Supply-Network/ArticleStandard/Article/detail/714717?contextCategoryId=43001&ref=25 Mergers and acquisitions expected to increase, as big companies bolster piplines by acquiring smaller biotech companies. 2011-04-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142011/714717null XML http://www.biopharminternational.com/biopharm/Outsourcing/Key-Considerations-When-Outsourcing-Cell-Culture-M/ArticleStandard/Article/detail/711282?contextCategoryId=43001&ref=25 The authors examine several issues that will help streamline negotiations between a service provider and a cell-culture medium consumer. 2011-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/112011/711282null XML http://www.biopharminternational.com/biopharm/Outsourcing/Successful-Technology-Transfer-Process-Validation-/ArticleStandard/Article/detail/711283?contextCategoryId=43001&ref=25 The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO. 2011-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/112011/711283null XML http://www.biopharminternational.com/biopharm/Outsourcing/Sponsor-CMO-Conflict-Management-for-Clinical-Phase/ArticleStandard/Article/detail/711281?contextCategoryId=43001&ref=25 The authors present the CMO's perspective on various potential sources of sponsor-CMO conflicts. 2011-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/112011/711281null XML http://www.biopharminternational.com/biopharm/Outsourcing/Supply-Chain-Transformation-Strategic-Necessity-fo/ArticleStandard/Article/detail/711284?contextCategoryId=43001&ref=25 New supply-chain challenges are forcing companies to act in different ways to secure product safety. 2011-03-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/112011/711284/BP0311_96502254_web_flash.jpg XML http://www.biopharminternational.com/biopharm/Outsourcing/First-Hand-Look-at-Indias-Pharma-Services-Sector/ArticleStandard/Article/detail/711069?contextCategoryId=43001&ref=25 Indian manufacturers are not now a threat to Western CMOs, but may be long term. 2011-03-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/112011/711069null XML http://www.biopharminternational.com/biopharm/Outsourcing/Driving-your-Product-to-Profitability-with-Project/ArticleStandard/Article/detail/707025?contextCategoryId=43001&ref=25 Biotech companies will have a much better shot at success with a project management plan and team in place from the very outset 2011-02-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/072011/707025null XML http://www.biopharminternational.com/biopharm/Outsourcing/What-to-Watch-For-in-2011/ArticleStandard/Article/detail/703597?contextCategoryId=43001&ref=25 CDMOs and CMOs face weak economic recovery, consolidation, and globalization. 2011-01-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/032011/703597null XML http://www.biopharminternational.com/biopharm/Outsourcing/Winning-Big/ArticleStandard/Article/detail/698529?contextCategoryId=43001&ref=25 Covance's deal with Sanofi-Aventis demonstrates the power of scale and scope. 2010-12-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/492010/698529null XML http://www.biopharminternational.com/biopharm/Outsourcing/Uncertain-Outlook-for-Biopharma-Venture-Capital/ArticleStandard/Article/detail/690803?contextCategoryId=43001&ref=25 Venture capital is still scarce for early biotechs and their providers. 2010-10-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/422010/690803null XML http://www.biopharminternational.com/biopharm/Outsourcing/Build-Versus-Buy-in-the-Current-Biotech-Market-Env/ArticleStandard/Article/detail/685439?contextCategoryId=43001&ref=25 How current economic conditions affect your build-or-buy decision. 2010-09-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/362010/685439null XML http://www.biopharminternational.com/biopharm/Outsourcing/Spanning-the-Globe/ArticleStandard/Article/detail/683151?contextCategoryId=43001&ref=25 This month, we catch up on major developments around the world and their implications for the contract services industry. 2010-08-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/332010/683151null XML http://www.biopharminternational.com/biopharm/Quality%2FGMP%2FValidation++Whitepapers/How-to-Apply-Risk-Assessment-Techniques-to-Outsour/ArticleStandard/Article/detail/677307?contextCategoryId=43001&ref=25 Apply risk management principles to monitor outsourced activities. 2010-07-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/272010/677307/bp0710_Scofield_flash.jpeg XML http://www.biopharminternational.com/biopharm/Outsourcing/How-Outsourcing-Can-Accelerate-Early-CMC-Developme/ArticleStandard/Article/detail/677314?contextCategoryId=43001&ref=25 How much to spend on early development, whether to use your CMO's proprietary cell line, and other outsourcing advice. 2010-07-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/272010/677314null XML http://www.biopharminternational.com/biopharm/Outsourcing/Out-of-Nowhere-Do-You-Need-to-Prepare-for-Highly-I/ArticleStandard/Article/detail/672428?contextCategoryId=43001&ref=25 Being open to unforseen events may avert risk or create opportunities. 2010-06-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/232010/672428null XML http://www.biopharminternational.com/biopharm/Outsourcing/Managing-CMOs-with-Complementary-Capabilities/ArticleStandard/Article/detail/667240?contextCategoryId=43001&ref=25 Formulation strategy is an important consideration when selecting and managing outsourced biopharmaceutical development programs. 2010-05-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/182010/667240null XML http://www.biopharminternational.com/biopharm/Outsourcing/Effective-Auditing-of-CMOs/ArticleStandard/Article/detail/663840?contextCategoryId=43001&ref=25 It is important that all stages of the audit be given an equal measure of attention. 2010-04-02T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142010/663840null XML http://www.biopharminternational.com/biopharm/Outsourcing/How-to-Reap-the-Benefits-of-Insourcing-Contract-St/ArticleStandard/Article/detail/663841?contextCategoryId=43001&ref=25 Insourcing is new outsourcing. Here's how to do it right. 2010-04-02T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142010/663841null XML http://www.biopharminternational.com/biopharm/Outsourcing/Process-Harmonization-Assessments-for-Technology-T/ArticleStandard/Article/detail/663842?contextCategoryId=43001&ref=25 A process harmonization assessment can aid in smooth technology transfer by comparing data across equipment and sites. 2010-04-02T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142010/663842null XML http://www.biopharminternational.com/biopharm/Outsourcing/Strategies-for-Optimizing-the-CMO-Client-Relations/ArticleStandard/Article/detail/663839?contextCategoryId=43001&ref=25 Partner with a contract manufacturing organization that integrates best practices from project management, customer service, and Lean. 2010-04-02T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142010/663839null XML http://www.biopharminternational.com/biopharm/Outsourcing/Complex-Clinical-Trials-are-Posing-New-Challenges-/ArticleStandard/Article/detail/663862?contextCategoryId=43001&ref=25 The ability to deal with the complexity of the clinical supply process has shifted the balance of power to clinical supply chain specialists. 2010-04-01T04:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/142010/663862null XML http://www.biopharminternational.com/biopharm/Outsourcing/Indias-Future-as-a-Biologics-Manufacturing-Hub/ArticleStandard/Article/detail/659501?contextCategoryId=43001&ref=25 Collaborations between Western and Indian companies may provide the best path for offshoring successfully and for developing India's readiness. 2010-03-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102010/659501null XML http://www.biopharminternational.com/biopharm/Outsourcing/The-Role-of-Process-History-in-Establishing-Clear-/ArticleStandard/Article/detail/659500?contextCategoryId=43001&ref=25 Sufficient process history is key to the rapid transfer of your process. 2010-03-01T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/102010/659500/bp0310_Glacken_flash.jpg XML http://www.biopharminternational.com/biopharm/Quality/Podcast-Series/ArticleStandard/Article/detail/654741?contextCategoryId=43001&ref=25 UPLC, QTof, HDMS, and more: A practical guide to the hottest techniques driving the future of biopharmaceutical science. 2010-02-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/062010/654741null XML http://www.biopharminternational.com/biopharm/Quality/Resources/ArticleStandard/Article/detail/654739?contextCategoryId=43001&ref=25 If you are looking for additional information (or terms not included in our glossary), here are some places to begin your search. 2010-02-02T05:00:00Z http://www.biopharminternational.com/biopharm/data/articlestandard/biopharm/062010/654739null XML